Symptomatic Transthyretin Amyloid Cardiomyopathy
1 clinical trials · Condition
◉ Watch Symptomatic Transthyretin Amyloid Cardiomyopathy
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CM (NCT04622046) | Alexion Pharmaceuticals, Inc. | 2020-11-13 |
Track Symptomatic Transthyretin Amyloid Cardiomyopathy automatically
Every clearance here is in the API, with alerts when new ones post.